Uganda's Health Ministry orders $1.8 million worth of antiretrovirals to address drug shortage

Uganda's Ministry of Health is expecting a batch of antiretroviral drugs to "arrive any time," Sam Zaramba, director-general of health services, announced on Tuesday following a drug shortage confirmed by health officials in the country last week, the New Vision/AllAfrica.com reports.

The government order for $1.8 million worth of antiretrovirals was placed with Quality Chemicals, a pharmaceutical company based in Uganda's capital of Kampala. According to Quality Chemicals' CEO Emmanuel Katongole, the first batch of the drugs is scheduled to be delivered this week. Zaramba said the drug shortage is temporary and that there is "no need to panic because we are ensuring that [the antiretrovirals] are delivered on time." Zaramba added that an increased demand for antiretrovirals and a scarcity of ingredients needed to produce the drugs are creating a global shortage.

According to the New Vision/AllAfrica.com, about 1,500 people are enrolled in Uganda's antiretroviral treatment program monthly. In addition, 312,000 people in the country are in immediate need of antiretrovirals -- an increase from approximately 225,000 people in 2006. About 42% -- or 130,000 people -- of the total number of people in urgent need of the drugs are receiving the medications, according to the New Vision/AllAfrica.com (Bugembe, New Vision/AllAfrica.com, 8/28).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small Solutions for Big Problems in Drug Discovery and Delivery